ATC Group: J05AH02 Oseltamivir

Position of J05AH02 in the ATC hierarchy

Level	Code	Title
1	J	Antiinfectives for systemic use
2	J05	Antivirals for systemic use
3	J05A	Direct acting antivirals
4	J05AH	Neuraminidase inhibitors
5	J05AH02	Oseltamivir

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code	Route	Amount	Notes
ORAL	Oral	0.15 g

Active ingredients in J05AH02

Active Ingredient
Oseltamivir
Oseltamivir (oseltamivir carboxylate) is a selective inhibitor of influenza virus neuraminidase enzymes, which are glycoproteins found on the virion surface. Viral neuraminidase enzyme activity is important both for viral entry into uninfected cells and for the release of recently formed virus particles from infected cells, and for the further spread of infectious virus in the body.

Related product monographs

Document	Type	Information Source
EBILFUMIN Hard capsule	MPI, EU: SmPC	European Medicines Agency (EU)
NATFLU Hard capsule	MPI, Generic	Health Sciences Authority (SG)
OSELFLU Gelatin capsule	MPI, Generic	Health Products Regulatory Authority (ZA)
TAMIFLU Hard capsule	MPI, EU: SmPC	European Medicines Agency (EU)
TAMIFLU Powder for oral suspension	MPI, EU: SmPC	European Medicines Agency (EU)

Medicines in this ATC group

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.